Headline
The latest stories from AHA Today.
The Federal Emergency Management Agency released a COVID-19 pandemic advisory describing in general terms what actions it is taking, how community-based testing sites will be managed, and information about the Defense Production Act.
In response to the COVID-19 outbreak, the Food and Drug Administration released updated guidance to provide flexibility and expand the availability of ventilators and other respiratory devices to treat patients during the public health emergency.
Leaders from the Senate and administration continue to negotiate a third spending package related to COVID-19.
The Coalition to Protect America’s Health Care, of which the AHA is a founding member, launched a digital campaign urging 2.2 million members to encourage their lawmakers to include in the new emergency funding package funding for hospitals to protect the health care workforce and increase their…
At an AHA press briefing today, hospital and health system leaders from across the country described the urgent need for federal aid to ensure that frontline medical personnel have the tools and resources they need to effectively respond to the COVID-19 crisis.
Health care providers can now use FDA-cleared non-invasive remote devices to monitor a patient’s vital signs, the agency said.
CMS has approved a Section 1135 waiver for Washington state’s Medicaid program, making the state the second such recipient. The waiver streamlines Washington’s process of provider enrollment, allowing the state to temporarily waive providers’ application and enrollment fees, criminal and background…
The Food and Drug Administration reinforced the need for blood donations, encouraging healthy individuals who are able to do so.
The Accreditation Council for Graduate Medical Education announced it is suspending routine GME operations to allow organizations and faculty members to focus on the needs of patients with COVID-19 and “the careful and appropriate integration of residents and fellows into that process.”
The Food and Drug Administration has updated its COVID-19 diagnostic testing FAQs, a reference for clinical laboratories, commercial manufacturers, and Food and Drug Administration staff.